Ultragenyx Pharmaceutical
RARE
RARE
232 hedge funds and large institutions have $5.69B invested in Ultragenyx Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 95 increasing their positions, 70 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
232
Holders Change
+12
Holders Change %
+5.45%
% of All Funds
3.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
95
Reduced
70
Closed
19
Calls
$874K
Puts
$8.01M
Net Calls
-$7.13M
Net Calls Change
-$5.83M
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$115M |
| 2 |
SCM
Suvretta Capital Management
New York
|
+$40.8M |
| 3 |
ClearBridge Investments
New York
|
+$34.7M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$31M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$20.6M |
